Brief: AC Immune To Regain Global Rights To Crenezumab And Semorinemab

AC Immune AG

22/01/2024 12:31

Jan 22 (Reuters) - AC Immune SA  ACIU.O :
    * AC IMMUNE TO REGAIN GLOBAL RIGHTS TO CRENEZUMAB AND
SEMORINEMAB
    * AC IMMUNE SA-TO REGAIN RIGHTS TO EXISTING GMP DRUG-PRODUCT
FOR
CLINICAL TESTING AS WELL AS ASSOCIATED DATA GENERATED UNDER EACH
OF AGREEMENTS WITH GENENTECH

Source text for Eikon:  ID:nGNX25nrJv 
Further company coverage:  ACIU.O 

 ((Reuters.Briefs@thomsonreuters.com;))